bioRxivMicrobiologyPreprint
Successful introduction of the Colour Test into inexperienced settings
K. Klaos, A. Agejeva, T. Kummik, S. Laks, O. Remets, S. Sasi, A. Tann, P. Viiklepp, A. Altraja
Abstract
Implementation of non-commercial in-house methods into routine clinical diagnostics becomes more challenging, because these methods are not internationally standardized, most of the research in that field is underfunded and recommendations for their use is lacking. We conducted a study, where all the technicians were previously unfamiliar to the Colour Test (CT), a colorimetric redox indicator and thin-layer agar based Mycobacterium tuberculosis complex diagnosis and direct drug susceptibility testing (DST) method, and tested whether the performance of this in-house method is dependent on experience of the laboratory personnel. After a two-day hands-on training, six panels of 150 M. tuberculosis isolates were cultured onto CT plates prepared in-house by six technicians in two laboratories. Finally, triplicate readings of 900 CT plates resulted 18 DST patterns for each of the initial isolates. The results were compared to each other and the gold standard of BACTEC MGIT 960 DST results. The median time to produce M. tuberculosis CT DST results for three antituberculosis drugs was 13 days. The overall ability to correctly define phenotypic resistance ranged from 94.7% for levofloxacin to 95.8% and 97.3% for isoniazid and rifampicin, respectively. The test specificities were even higher exceeding 97% for all three drugs tested. Interobserver agreement reached 100% in one of the laboratories and exceeded 97% for levofloxacin and 99% for isoniazid and rifampicin in the second laboratory. The implementation of the CT into a new laboratory was straightforward with only minimal guidance. This study proves that the CT is highly reproducible and easily interpreted by previously inexperienced personnel.
- research focus: host-pathogen & immune response
- research focus: drug response / drug discovery
- research focus: benchmarking
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Tre-DST: A new drug susceptibility test for Mycobacterium tuberculosis using solvatochromic trehalose probes
Lilith A. Schwartz, Adriann L. Brodeth, … Mireille Kamariza·ACS Infectious DiseasesPeer-reviewed·Dec 19, 2025
- Xpert MTB/XDR: A ten-color reflex assay suitable for point of care settings to detect isoniazid-, fluoroquinolone-, and second line injectable drug-resistance directly from Mycobacterium tuberculosis positive sputum.
Y. Cao, H. Parmar, … S. Chakravorty·bioRxiv·Sep 8, 2020
- Direct thin-layer agar for bedaquiline-susceptibility testing of Mycobacterium tuberculosis at BSL2 level yields high accuracy in 15 days from sputum processing.
Isabel Cuella Martin, Docteur Runyambo, … L. Rigouts·Journal of Clinical MicrobiologyPeer-reviewed·Mar 3, 2025
- Diagnostic Accuracy of FluoroCycler XT MTBDR Assay for Detection of Rifampicin and Isoniazid Resistant Mycobacteria tuberculosis in Clinical Isolates from Kenya
Zakayo Maingi Mwangi, Samson Ireri, … Nellie Mukiri·bioRxiv·May 17, 2023
- Demonstration of a fast and easy sample-to-answer protocol for Mycobacterium tuberculosis diagnosis in point-of-care settings
Nasir Ali, Graziele Lima Bello, … Marco Aurélio Krieger·bioRxiv·Apr 7, 2019
- Validating a 14-drug microtitre plate containing bedaquiline and delamanid for large-scale research susceptibility testing of Mycobacterium tuberculosis
P. M. Rancoita, F. Cugnata, … the CRyPTIC Consortium·bioRxiv·Jun 15, 2018